Artículos de revistas sobre el tema "Β1-Blockers"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Β1-Blockers".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage y Robert J. Hancox. "The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports". ERJ Open Research 7, n.º 1 (enero de 2021): 00801–2020. http://dx.doi.org/10.1183/23120541.00801-2020.
Texto completodo Vale, Gabriel T., Carla S. Ceron, Natália A. Gonzaga, Janaina A. Simplicio y Júlio C. Padovan. "Three Generations of β-blockers: History, Class Differences and Clinical Applicability". Current Hypertension Reviews 15, n.º 1 (29 de enero de 2019): 22–31. http://dx.doi.org/10.2174/1573402114666180918102735.
Texto completoKaroli, N. A. y A. P. Rebrov. "Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease". Kardiologiia 61, n.º 10 (30 de octubre de 2021): 89–98. http://dx.doi.org/10.18087/cardio.2021.10.n1119.
Texto completoStănciulescu, Maria-Corina, Marius-Călin Popoiu, Anca Maria Cîmpean, Vlad-Laurentiu David, Rodica Heredea, Simona Cerbu y Eugen-Sorin Boia. "Expression of β1 adrenergic receptor in vascular anomalies in children". Journal of International Medical Research 49, n.º 9 (septiembre de 2021): 030006052110477. http://dx.doi.org/10.1177/03000605211047713.
Texto completoBarcella, Carlo A., Talip E. Eroglu, Michiel Hulleman, Asger Granfeldt, Patrick C. Souverein, Grimur H. Mohr, Rudolph W. Koster et al. "Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries". EP Europace 22, n.º 8 (28 de junio de 2020): 1206–15. http://dx.doi.org/10.1093/europace/euaa124.
Texto completoGrande, Fedora, Anna De Bartolo, Maria Antonietta Occhiuzzi, Anna Caruso, Carmine Rocca, Teresa Pasqua, Alessia Carocci, Vittoria Rago, Tommaso Angelone y Maria Stefania Sinicropi. "Carbazole and Simplified Derivatives: Novel Tools toward β-Adrenergic Receptors Targeting". Applied Sciences 11, n.º 12 (13 de junio de 2021): 5486. http://dx.doi.org/10.3390/app11125486.
Texto completoArtym, Vira V. y Howard R. Petty. "Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and β1-Integrins on the Plasma Membrane of Melanoma Cells". Journal of General Physiology 120, n.º 1 (10 de junio de 2002): 29–37. http://dx.doi.org/10.1085/jgp.20028607.
Texto completoSingh, Bramah N. "β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview". Journal of Cardiovascular Pharmacology and Therapeutics 10, n.º 4_suppl (octubre de 2005): S3—S14. http://dx.doi.org/10.1177/10742484050100i402.
Texto completoWinther, K. y C. Hedman. "Beta-Adrenoceptor Blockade, Platelets, and Rheologic Factors". Cephalalgia 6, n.º 5_suppl (mayo de 1986): 33–40. http://dx.doi.org/10.1177/03331024860060s504.
Texto completoDiniz, Gabriela Placoná, Marcela Sorelli Carneiro-Ramos y Maria Luiza Morais Barreto-Chaves. "Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors". International Journal of Endocrinology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/384890.
Texto completoClemente-Moragón, Agustín, Mónica Gómez, Rocío Villena-Gutiérrez, Doménica V. Lalama, Jaime García-Prieto, Fernando Martínez, Fátima Sánchez-Cabo, Valentín Fuster, Eduardo Oliver y Borja Ibáñez. "Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation". European Heart Journal 41, n.º 46 (7 de octubre de 2020): 4425–40. http://dx.doi.org/10.1093/eurheartj/ehaa733.
Texto completoNuttall, S. L., H. C. Routledge y M. J. Kendall. "A comparison of the β1 -selectivity of three β1 -selective β-blockers". Journal of Clinical Pharmacy and Therapeutics 28, n.º 3 (junio de 2003): 179–86. http://dx.doi.org/10.1046/j.1365-2710.2003.00477.x.
Texto completoWAJIMA, Zen'ichiro. "Future Possibilities for the Clinical Use of β1-blockers". JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 26, n.º 4 (2006): 398–403. http://dx.doi.org/10.2199/jjsca.26.398.
Texto completoNakaya, Michio, Satsuki Chikura, Kenji Watari, Natsumi Mizuno, Koji Mochinaga, Supachoke Mangmool, Satoru Koyanagi et al. "Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways". Journal of Biological Chemistry 287, n.º 42 (10 de agosto de 2012): 35669–77. http://dx.doi.org/10.1074/jbc.m112.357871.
Texto completoÁblad, Bengt y Carl Dahlöf. "Migraine and β-Blockade: Modulation of Sympathetic Neurotransmission". Cephalalgia 6, n.º 5_suppl (mayo de 1986): 7–14. http://dx.doi.org/10.1177/03331024860060s501.
Texto completoBlaauw, Erik, Frans A. van Nieuwenhoven, Peter Willemsen, Tammo Delhaas, Frits W. Prinzen, Luc H. Snoeckx, Marc van Bilsen y Ger J. van der Vusse. "Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes". American Journal of Physiology-Heart and Circulatory Physiology 299, n.º 3 (septiembre de 2010): H780—H787. http://dx.doi.org/10.1152/ajpheart.00822.2009.
Texto completoAshes, Catherine, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare y W. Scott Beattie. "Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol". Anesthesiology 119, n.º 4 (1 de octubre de 2013): 777–87. http://dx.doi.org/10.1097/aln.0b013e3182a17f12.
Texto completoPeltenburg, Puck J., Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy et al. "An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation 145, n.º 5 (febrero de 2022): 333–44. http://dx.doi.org/10.1161/circulationaha.121.056018.
Texto completoDurgaryan, Ruzan. "C0159 β1 blockers, warfarin and rhythm conversion in atrial fibrillation". Thrombosis Research 130 (octubre de 2012): S173. http://dx.doi.org/10.1016/j.thromres.2012.08.188.
Texto completoFedorov, V. N., V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov y S. S. Suleymanov. "Pharmacotherapy of glaucoma in terms of evidence-based medicine". Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, n.º 3 (20 de octubre de 2023): 44–54. http://dx.doi.org/10.37489/2588-0519-2023-3-44-54.
Texto completoGeng, Yanyan, Xiaoyu Wang y Karl L. Magleby. "Lack of negative slope in I-V plots for BK channels at positive potentials in the absence of intracellular blockers". Journal of General Physiology 141, n.º 4 (25 de marzo de 2013): 493–97. http://dx.doi.org/10.1085/jgp.201210955.
Texto completoYi, Sheng, Fernando Pierucci-Alves y Bruce D. Schultz. "Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway". American Journal of Physiology-Cell Physiology 305, n.º 8 (15 de octubre de 2013): C867—C876. http://dx.doi.org/10.1152/ajpcell.00121.2013.
Texto completoCasabella-Ramón, Sergi, Verónica Jiménez-Sábado, Carmen Tarifa, Sandra Casellas, Tien Tina Lu, Paloma Izquierdo-Castro, Ignasi Gich et al. "Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes". Biomedicines 10, n.º 7 (21 de julio de 2022): 1759. http://dx.doi.org/10.3390/biomedicines10071759.
Texto completoFarhoumand, Lina S., Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis y Utta Berchner-Pfannschmidt. "Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures". International Journal of Molecular Sciences 24, n.º 6 (20 de marzo de 2023): 5894. http://dx.doi.org/10.3390/ijms24065894.
Texto completoWydra, Wioletta y Marek Kuch. "Nebivolol – a place in the therapy of hypertension in various clinical situations". Medycyna Faktów 14, n.º 2 (30 de junio de 2021): 195–200. http://dx.doi.org/10.24292/01.mf.0221.9.
Texto completoVerdecchia, Paolo, Claudio Cavallini, Stefano Coiro, Clara Riccini y Fabio Angeli. "Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease". European Heart Journal Supplements 23, Supplement_E (1 de octubre de 2021): E172—E176. http://dx.doi.org/10.1093/eurheartj/suab116.
Texto completoFloria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi et al. "An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation". Pharmaceutics 16, n.º 4 (8 de abril de 2024): 517. http://dx.doi.org/10.3390/pharmaceutics16040517.
Texto completoSchnabel, Petra, Christoph Maack, Florian Mies, Stephan Tyroller, Alexander Scheer y Michael Böhm. "Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors". Journal of Cardiovascular Pharmacology 36, n.º 4 (octubre de 2000): 466–71. http://dx.doi.org/10.1097/00005344-200010000-00008.
Texto completoMizogami, Maki, Ko Takakura y Hironori Tsuchiya. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 27, n.º 9 (septiembre de 2010): 829–34. http://dx.doi.org/10.1097/eja.0b013e32833bf5e4.
Texto completo&NA;. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 29, n.º 5 (mayo de 2012): 255. http://dx.doi.org/10.1097/eja.0b013e328353b02b.
Texto completoBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni y Paola Massarelli. "Synthesis, binding affinity and selectivity of new β1- and β2-adrenoceptor blockers". Il Farmaco 54, n.º 11-12 (noviembre de 1999): 713–20. http://dx.doi.org/10.1016/s0014-827x(99)00077-4.
Texto completoRizos, Ioannis K., James N. Tsoporis, Ioannis K. Toumpoulis, Vasileios Salpeas, Shehla Izhar, Angelos G. Rigopoulos, Eleftherios A. Sakadakis y Thomas G. Parker. "Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells". Journal of Cardiovascular Pharmacology 72, n.º 2 (agosto de 2018): 86–96. http://dx.doi.org/10.1097/fjc.0000000000000596.
Texto completoChaudhari, Sarika, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E. Davis, Jonathan E. Zuckerman y Rong Ma. "Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 313, n.º 3 (1 de septiembre de 2017): F729—F739. http://dx.doi.org/10.1152/ajprenal.00483.2016.
Texto completoKähönen, Mika, Ritva Ylitalo, Tiit Kööbi, Väinö Turjanmaa y Pauli Ylitalo. "Influences of nonselective, β1-selective and vasodilatory β1-selective β-blockers on arterial pulse wave velocity in normotensive subjects". General Pharmacology: The Vascular System 35, n.º 4 (octubre de 2000): 219–24. http://dx.doi.org/10.1016/s0306-3623(01)00109-4.
Texto completoMiaron, J. O. O. y R. J. Christopherson. "Metabolic responses of the whole body, portal-drained viscera and hindquarter to adrenaline infusion: Effects of nonselective and selective β-adrenoceptor blockade". Canadian Journal of Animal Science 77, n.º 2 (1 de junio de 1997): 307–16. http://dx.doi.org/10.4141/a94-082.
Texto completoZhang, Y. Clare, Leping Shen y M. Ian Phillips. "An Antisense β1-Reducer: Repeated Administration Reduces Hypertension and Cardiac Hypertrophy Persistently Without Toxicity or Immune Response". Hypertension 36, suppl_1 (octubre de 2000): 691. http://dx.doi.org/10.1161/hyp.36.suppl_1.691.
Texto completoOngali, Brice, Nektaria Nicolakakis, Xin-Kang Tong, Clotilde Lecrux, Hans Imboden y Edith Hamel. "Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways". Canadian Journal of Physiology and Pharmacology 96, n.º 5 (mayo de 2018): 527–34. http://dx.doi.org/10.1139/cjpp-2017-0640.
Texto completoPark, Soo Hyun y Ho Jae Han. "The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells". American Journal of Physiology-Renal Physiology 282, n.º 2 (1 de febrero de 2002): F228—F237. http://dx.doi.org/10.1152/ajprenal.00080.2001.
Texto completoOzakca, Isil, Ebru Arioglu-Inan, Hrag Esfahani, V. Melih Altan, Jean-Luc Balligand, Gizem Kayki-Mutlu y A. Tanju Ozcelikay. "Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage". American Journal of Physiology-Heart and Circulatory Physiology 304, n.º 9 (1 de mayo de 2013): H1267—H1276. http://dx.doi.org/10.1152/ajpheart.00352.2012.
Texto completoKruik-Kollöffel, Willemien J., Job van der Palen, Carine J. M. Doggen, Marissa C. van Maaren, H. Joost Kruik, Edith M. Heintjes, Kris L. L. Movig y Gerard C. M. Linssen. "Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases". PLOS ONE 15, n.º 12 (22 de diciembre de 2020): e0244231. http://dx.doi.org/10.1371/journal.pone.0244231.
Texto completoGutierrez, Guillermo y Guillermo Ballarino. "Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!" Intensive Care Medicine 37, n.º 11 (17 de agosto de 2011): 1721–22. http://dx.doi.org/10.1007/s00134-011-2330-1.
Texto completoNemoto, Shinji, Yusuke Kasahara, Kazuhiro P. Izawa, Satoshi Watanabe, Kazuya Yoshizawa, Naoya Takeichi, Kentaro Kamiya et al. "Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction". International Journal of Environmental Research and Public Health 16, n.º 16 (8 de agosto de 2019): 2838. http://dx.doi.org/10.3390/ijerph16162838.
Texto completoBrahmbhatt, Shruti Vihang y Bhagya M. Sattigeri. "A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital". International Journal of Basic & Clinical Pharmacology 7, n.º 11 (23 de octubre de 2018): 2196. http://dx.doi.org/10.18203/2319-2003.ijbcp20184327.
Texto completoPillozzi, Serena, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei et al. "Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers". Blood 117, n.º 3 (20 de enero de 2011): 902–14. http://dx.doi.org/10.1182/blood-2010-01-262691.
Texto completoPolakovičová, M. y R. Čižmáriková. "Molecular Docking Study on the Binding Mode of Cardioselective Phenoxyaminopropanol Blocker into β-adrenergic Receptor Subtypes". Acta Facultatis Pharmaceuticae Universitatis Comenianae 59, n.º 2 (28 de diciembre de 2012): 44–53. http://dx.doi.org/10.2478/v10219-012-0024-6.
Texto completoAhmed, Maruf, Habib Abul Muntasir, Murad Hossain, Masaji Ishiguro, Tadazumi Komiyama, Ikunobu Muramatsu, Hitoshi Kurose y Takafumi Nagatomo. "Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor". Journal of Pharmacological Sciences 102, n.º 2 (2006): 167–72. http://dx.doi.org/10.1254/jphs.fp0060640.
Texto completoSong, Hong Ji, Joongyub Lee, Ye-Jee Kim, Sun-Young Jung, Hwa Jung Kim, Nam-Kyong Choi y Byung-Joo Park. "β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients". Bone 51, n.º 6 (diciembre de 2012): 1008–15. http://dx.doi.org/10.1016/j.bone.2012.08.126.
Texto completoBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni y Paola Massarelli. "ChemInform Abstract: Synthesis, Binding Affinity, and Selectivity of New β1- and β2-Adrenoceptor Blockers." ChemInform 31, n.º 12 (9 de junio de 2010): no. http://dx.doi.org/10.1002/chin.200012248.
Texto completoJia, Haiyan, Sue Monteith y Morris J. Brown. "Expression of the α- and β-Subunits of the Stimulatory and Inhibitory G-Proteins in β1-Adrenoceptor-Blocked and non-β-Adrenoceptor-Blocked Human Atrium". Clinical Science 88, n.º 5 (1 de mayo de 1995): 571–80. http://dx.doi.org/10.1042/cs0880571.
Texto completoGao, Xiaomeng, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa, Fan Yang y Qingyou Xu. "Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice". International Journal of Molecular Sciences 24, n.º 14 (21 de julio de 2023): 11766. http://dx.doi.org/10.3390/ijms241411766.
Texto completo